TARS earnings date and last-quarter result: next report 2026-08-06, last quarter miss, P/E -50.51. Updated 2026-07-23.
Tarsus Pharmaceuticals (TARS) Research Hub
Tarsus Pharmaceuticals (TARS) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 70.03 USD (+2.68%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -50.51, market cap 2.48B. This hub links to the full technical, earnings and options research available for TARS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 70.03 USD (+2.68%) |
| 52-week range | 53.89 USD – 91.53 USD |
| Trend regime | Range |
| 14-day RSI | 41.5 (Bearish) |
| Trailing P/E | -50.51 |
| Market cap | 2.48B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for TARS
Covered Call on TARS: how it works, illustrative setup around the real 70.03 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TARS: how it works, illustrative setup around the real 70.03 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TARS: how it works, illustrative setup around the real 70.03 USD price, max profit/loss, breakeven and when to use it. Educational.
TARS technical analysis: range, last 70.03 USD, RSI 41.5, 52w range 53.89 USD–91.53 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is TARS in?
Tarsus Pharmaceuticals (TARS) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is TARS in an uptrend or downtrend?
As of 2026-10-26, TARS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TARS's trailing P/E ratio?
TARS's trailing P/E is -50.51, with a market cap of 2.48B. See the earnings research page for full valuation detail.
When does TARS next report earnings?
TARS is next scheduled to report earnings on 2026-08-06.